To test our observations on autoimmune mice in humans, we chose to investigate patients with RA, following studies by others in which antibody blockade of ICAM-1 in such patients was reported to have beneficial effects on various clinical parameters, although no data on the effects on B cells were published (16). This evidence concerns the gene ICAM1 and rheumatoid arthritis.